User talk:Born2cycle/armstrong-allegations

Although American cyclist Lance Armstrong has never been found guilty of doping by cycling officials, many allegations of misconduct have been made by professional riders and others surrounding him. Armstrong has spent considerable time and money defending himself against accusations made by his accusers, and speculation as to whether or not he used performance-enhancing drugs to achieve his successes on the bike, which include winning general classification in the Tour de France a record seven times, continues to follow him even after retiring from the race a second time in 2010.

Specific allegations

• Armstrong has been criticized for working with controversial trainer Michele Ferrari. Greg Lemond described himself as "devastated" on hearing of them working together, while Tour de France organizer Jean-Marie Leblanc said, "I am not happy the two names are mixed." Following Ferrari's later-overturned conviction for "sporting fraud" and "abuse of the medical profession", Armstrong suspended his professional relationship with him, saying that he had "zero tolerance for anyone convicted of using or facilitating the use of performance-enhancing drugs" and denying that Ferrari had ever "suggested, prescribed or provided me with any performance-enhancing drugs." Ferrari was later absolved of all charges by an Italian appeals court of the sporting fraud charges as well as charges of abusing his medical license to write prescriptions. The court stated that it overturned his conviction "because the facts do not exist" to support the charges.

• In 2004, reporters Pierre Ballester and David Walsh published a book alleging Armstrong had used performance-enhancing drugs (L. A. Confidentiel - Les secrets de Lance Armstrong). It contains allegations by Armstrong's former masseuse, Emma O'Reilly, who claimed Armstrong once asked her to dispose of used syringes and to give him makeup to conceal needle marks on his arms. Another figure in the book, Steve Swart, claims he and other riders, including Armstrong, began using drugs in 1995 while members of the Motorola team, a claim denied by other team members. Allegations in the book were reprinted in the UK newspaper The Sunday Times in a story by deputy sports editor Alan English in June 2004. Armstrong sued for libel, and the paper settled out of court after a High Court judge in a pre-trial ruling stated that the article "meant accusation of guilt and not simply reasonable grounds to suspect." The newspaper's lawyers issued the statement: "The Sunday Times has confirmed to Mr. Armstrong that it never intended to accuse him of being guilty of taking any performance-enhancing drugs and sincerely apologised for any such impression." (See also in The Guardian). Armstrong later dropped similar lawsuits in France.

• On March 31, 2005, Mike Anderson filed a brief in Travis County District Court in Texas, as part of a legal battle following his termination in November 2004 as an employee of Armstrong. Anderson worked for Armstrong for two years as a personal assistant. In the brief, Anderson claimed that he discovered a box of androstenone while cleaning a bathroom in Armstrong's apartment in Girona, Spain. Androstenone is not on the list of banned drugs. Anderson stated in a subsequent deposition that he had no direct knowledge of Armstrong using a banned substance. Armstrong denied the claim and issued a counter-suit. The two men reached an out-of-court settlement in November 2005; the terms of the agreement were not disclosed.

• On August 23, 2005, L'Équipe, a major French daily sports newspaper, reported on its front page under the headline "le mensonge Armstrong" ("The Armstrong Lie") that 6 urine samples taken from the cyclist during the prologue and five stages of the 1999 Tour de France, frozen and stored since at "Laboratoire national de dépistage du dopage de Châtenay-Malabry" (LNDD), had tested positive for erythropoietin in recent retesting conducted as part of a research project into EPO testing methods. For years, it had been impossible to detect erythropoietin, which boosts the production of oxygen-carrying red blood cells. The world governing body of cycling, Union Cycliste Internationale (UCI), did not begin using a urine test for EPO until 2001, two years after the samples were taken. This claim was based on an investigation in which they claimed to be able to match samples from the 1999 Tour that were used to hone the EPO test to Armstrong. To establish a link between Armstrong and the samples, Damien Ressiot, L'Equipe's reporter, matched the tracking numbers, with the indirect help of UCI and Lance Armstrong on the samples with those on Armstrong's record with the UCI during the 1999 Tour. Armstrong immediately replied on his website, saying, "Unfortunately, the witch hunt continues and tomorrow's article is nothing short of tabloid journalism. The paper even admits in its own article that the science in question here is faulty and that I have no way to defend myself. They state: 'There will therefore be no counter-exam nor regulatory prosecutions, in a strict sense, since defendant's rights cannot be respected.' I will simply restate what I have said many times: I have never taken performance enhancing drugs." In October 2008, the AFLD gave Armstrong the opportunity to have samples taken during the 1998 and 1999 Tours de France retested. Armstrong immediately refused, saying, "the samples have not been maintained properly." Head of AFLD Pierre Bordry stated: "Scientifically there is no problem to analyse these samples - everything is correct" and "If the analysis is clean it would have been very good for him. But he doesn't want to do it and that's his problem." However, according to the results of an investigative report by Emile Vrijman (a Dutch lawyer and the former head of the Dutch anti-doping agency, which he headed for ten years), who was appointed by the UCI to head an independent investigations into the LNDD lab’s findings, it was determined that the analyses of the urine samples were conducted improperly and that they “did not satisfy any standard for doping control testing.” Vrijman’s report went on to state that handling and testing of the samples fell so far short of scientific standards, and that “the process that generated those results and the subsequent reports was so deficient” that it was "completely irresponsible" to suggest that the results could "constitute evidence of anything,” and cleared Armstrong of any wrongdoing.

• In June 2006, French newspaper Le Monde reported claims by Betsy and Frankie Andreu during a deposition that Armstrong had admitted using performance-enhancing drugs to his physician just after brain surgery in 1996. The Andreus' testimony was related to litigation between Armstrong and SCA Promotions, a Texas company attempting to withhold a $5-million bonus; this was settled out of court with SCA paying Armstrong and Tailwind Sports $7.5 million, to cover the $5-million bonus plus interest and lawyers' fees. The testimony stated "And so the doctor asked him a few questions, not many, and then one of the questions he asked was... have you ever used any performance-enhancing drugs? And Lance said yes. And the doctor asked, what were they? And Lance said, growth hormone, cortisone, EPO, steroids and testosterone." Armstrong suggested Betsy Andreu may have been confused by possible mention of his post-operative treatment which included steroids and EPO that are taken to counteract wasting and red-blood-cell-destroying effects of intensive chemotherapy. The Andreus' allegation was not supported by any of the eight other people present, including Armstrong's doctor Craig Nichols, or his medical history. According to Greg LeMond (who has been embroiled with his own disputes with Armstrong), he (LeMond) had a recorded conversation, the transcript of which was reviewed by National Public Radio, with Stephanie McIlvain (Armstrong's contact at Oakley Inc.) in which she said of Armstrong's alleged admission 'You know, I was in that room. I heard it.' However, McIlvain has contradicted LeMond allegations on the issue and denied under oath that the incident in question ever occurred in her sworn testimony.

• In July 2006, the Los Angeles Times published a story on the allegations raised in the SCA case. The report cited evidence at the trial including the results of the LNDD test and an analysis of these results by an expert witness. From the LA Times article: "The results, Australian researcher Michael Ashenden testified in Dallas, show Armstrong's levels rising and falling, consistent with a series of injections during the Tour. Ashenden, a paid expert retained by SCA Promotions, told arbitrators the results painted a "compelling picture" that the world's most famous cyclist "used EPO in the '99 Tour." Ashenden's finding were disputed by the Vrijman report, which pointed to procedural and privacy issues in dismissing the LNDD test results. The LA Times article also provided information on testimony given by Armstrong's former teammate, Swart, Andreu and his wife Betsy and instant messaging conversation between Andreu and Jonathan Vaughters regarding blood-doping in the peloton. Vaughters signed a statement disavowing the comments and stating he had: "no personal knowledge that any team in the Tour de France, including Armstrong's Discovery team in 2005, engaged in any prohibited conduct whatsoever." Andreu signed a statement affirming the conversation took place as indicated on the instant messaging logs submitted to the court. The SCA trial was settled out of court, and the LA Times reported: "Though no verdict or finding of facts was rendered, Armstrong called the outcome proof that the doping allegations were baseless." The L.A. Times' article provides a review of the disputed positive EPO test, allegations and sworn testimony against Armstrong, but notes that: "They are filled with conflicting testimony, hearsay and circumstantial evidence admissible in arbitration hearings but questionable in more formal legal proceedings."

• On May 20, 2010, former U.S. Postal teammate Floyd Landis accused Armstrong of doping in 2002 and 2003, and claimed that U.S. Postal team director Johan Bruyneel had bribed former UCI president Hein Verbruggen to keep quiet about a positive Armstrong test in 2002. Landis admitted there was no documentation that supports these claims. However, in July 2010 the president of the UCI, Pat McQuaid, revealed that Armstrong made two donations to the UCI: $25,000 in 2002, used by the juniors anti-doping program, and $100,000 in 2005, to buy a blood testing machine, and documentation of those payments does exist. Landis also maintains that he witnessed Armstrong receiving multiple blood transfusions, and dispensing testosterone patches to his teammates on the United States Postal Service Team.

• On May 25, 2010, The International Cycling Union disputed comments from Floyd Landis, "Due to the controversy following the statements made by Floyd Landis, the International Cycling Union wishes to stress that none of the tests revealed the presence of EPO in the samples taken from riders at the 2001 Tour of Switzerland," the UCI said in a statement. "The UCI has all the documentation to prove this fact." According to ESPN, "Landis claimed that Armstrong tested positive while winning in 2002, a timeline Armstrong himself said left him 'confused,' because he did not compete in the event in 2002."

• On June 9, 2010, The New York Daily News reported that assistant U.S. Attorney Doug Miller was the leader of a federal investigation into Landis's claims. Five days later the newspaper reported that Miller was overseeing a grand jury that had issued a subpoena to one of Armstrong's sponsors, the Trek bicycle company. On July 22, Los Angeles defense attorney Bryan Daly acknowledged that Armstrong had hired him to represent him in the probe.

References

Category:Doping cases in cycling